Innovative homogeneous assays for the instantaneous detection of viral, bacterial and tumour antigens
The technology is protected by the patent application n° 102016000073964. This new Ulisse BioMed platform is based on a molecular nanoswitch that detects protein analytes in complex matrices such as blood, saliva and vaginal mucus in less than 5 minutes, completely avoiding separation and washing steps. This technology can be shifted both on portable systems and on high-throughput platforms for the serial analysis of hundreds of samples. To date, there are no competitors with similar technology that is equally rapid, economical and effective.
PORTABLE DIAGNOSTIC DEVICES
A self-testing device detecting Human Papillomavirus
Easy Pap© will be the portable version of the biosensor-based detector able to detect the presence of Human Papillomavirus biomarkers. Ulisse BioMed aims at using this technological platform to detect the presence of other pathogens and tumour-specific biomarkers.
AMBULATORY DIAGNOSTIC DEVICES
Ambulatory devices detecting high risk HPV genotypes
This technology (patent MI2014A000146 with international PCT application nr. WO2015114506 A2) allows the detection of protein analytes in ambulatory, point-of-care systems. Ulisse BioMed is developing systems that detect the presence of high-risk strains of Human Papillomavirus, HIV and Toxoplasma in less than 15 minutes.
Innovative, quick and low cost HPV DNA tests
Ulisse BioMed is developing innovative systems for the detection of viral DNA directly in complex matrices such as vaginal mucus; these platforms can provide information on the presence of a specific viral genotype in less than one hour. The assays are user-friendly, low-cost and they can provide a wide spectrum of information: these are the main competitive advantages of this product line.